At Coastline Psychiatric Liaisons, we are committed to providing innovative, evidence-based treatments for individuals struggling with treatment-resistant mental health conditions. Under the leadership of Dr. Christina Lynn, our team offers Ketamine and Spravato® (Esketamine) therapy to help patients who have not found relief through traditional treatments. These advanced therapies provide new hope for individuals experiencing severe depression and other mental health disorders.

What is Ketamine Therapy?

Ketamine is a breakthrough treatment in mental health care, particularly for treatment-resistant depression (TRD), anxiety, PTSD, and bipolar disorder. Originally used as an anesthetic, ketamine has been shown to rapidly improve mood by stimulating the production of neurotransmitters and enhancing neural connections in the brain. Unlike traditional antidepressants, which may take weeks to show results, ketamine treatments often produce noticeable improvements within hours or days.

What is Spravato® (Esketamine)?

Spravato® is an FDA-approved nasal spray containing esketamine, a derivative of ketamine. It is specifically designed for individuals with treatment-resistant depression and major depressive disorder (MDD) with suicidal thoughts or behavior. Spravato® is administered under medical supervision at our clinic to ensure safety and effectiveness.

Benefits of Ketamine & Spravato® Therapy

• Rapid Relief – Many patients experience symptom improvement within hours or days.
• Effective for Treatment-Resistant Conditions – Helps individuals who have not responded to traditional antidepressants.
• Enhanced Brain Connectivity – Promotes neural growth and reduces depressive symptoms.
• Reduced Suicidal Thoughts – Provides an alternative for individuals in urgent need of relief.
• Minimal Side Effects – Unlike many psychiatric medications, ketamine has a lower risk of long-term side effects when administered correctly.